CDK4/6 inhibition suppresses mTOR activity and growth in lymphangioleiomyomatosis (LAM)

Nandini Kundu, Shahrzad S. Fard, Julie S. Di Martino, Marina K. Holz

Open source

DOI
10.1016/j.bbadis.2026.168513
Published
2027-02
Container
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bbadis.2026.168513,
  title = {CDK4/6 inhibition suppresses mTOR activity and growth in lymphangioleiomyomatosis (LAM)},
  author = {Nandini Kundu and Shahrzad S. Fard and Julie S. Di Martino and Marina K. Holz},
  year = {2027},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  doi = {10.1016/j.bbadis.2026.168513},
  url = {https://doi.org/10.1016/j.bbadis.2026.168513}
}

RIS

TY  - JOUR
TI  - CDK4/6 inhibition suppresses mTOR activity and growth in lymphangioleiomyomatosis (LAM)
AU  - Nandini Kundu
AU  - Shahrzad S. Fard
AU  - Julie S. Di Martino
AU  - Marina K. Holz
PY  - 2027
JO  - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DO  - 10.1016/j.bbadis.2026.168513
UR  - https://doi.org/10.1016/j.bbadis.2026.168513
ER  - 

APA

Kundu, N., Fard, S. S., Martino, J. S. D., & Holz, M. K. (2027). CDK4/6 inhibition suppresses mTOR activity and growth in lymphangioleiomyomatosis (LAM). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2026.168513

Source records